Block-Copolymer Encapsulation for Uniform, Targeted Nanocomposites

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods of polymer encapsulation of nanoparticles such as QD or SPION result in agglomeration, limit production to small batches, lack photochemical stability, uniform size and brightness, and specificity to cellular targets, and lack rapid purification protocols.

Innovation Solution

A nanocomposite system comprising hydrophobic nanoparticles encapsulated in a hydrophilic polymer with a functional group, using polystyrene-b-polyethylene glycol, allows for uniform size distribution, high brightness, and specific binding to cellular targets, with SPION nanocomposites isolatable by magnetic fields.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current polymer encapsulation methods are used, then nanoparticle encapsulation is achieved, but agglomeration occurs and production is limited to small batches

Engineering Contradiction:
Improveproduction batch sizeVSAvoidnanocomposite agglomeration
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent uses a block copolymer composed of hydrophobic polystyrene blocks and hydrophilic polyethylene glycol blocks to encapsulate hydrophobic nanoparticles. The hydrophobic blocks interact with the nanoparticle surface while the hydrophilic blocks extend into the aqueous medium, creating a stable composite structure that prevents agglomeration and enables large-scale production.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent optimizes the molecular weights of the polystyrene and polyethylene glycol blocks, as well as their mass ratios, to control the hydrodynamic diameter and stability of the nanocomposites. By adjusting these parameters, the system achieves uniform size distribution and prevents agglomeration while maintaining high productivity.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If polymer encapsulation is performed, then nanoparticle stabilization is achieved, but uniform size and brightness are not obtained

Engineering Contradiction:
Improvesize uniformityVSAvoidphotochemical stability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent systematically optimizes the molecular weights of the polystyrene (1.5-40 kDa) and polyethylene glycol (10-40 kDa) blocks, along with their mass ratios, to achieve uniform hydrodynamic diameters (40-500 nm) and consistent brightness. This parameter optimization ensures both size uniformity and photochemical stability of the quantum dots.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If nanocomposites are produced, then nanoparticle encapsulation is achieved, but specificity to cellular targets is lacking

Engineering Contradiction:
Improvecellular target binding specificityVSAvoidconjugate production
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent introduces specific functional groups (amine, carboxyl, hydroxyl, thiol) at the hydrophilic polyethylene glycol region of the block copolymer. These functional groups are positioned specifically to enable selective conjugation with antibodies or other targeting molecules, providing cellular target specificity while maintaining ease of manufacture through standardized conjugation protocols.

Inventive Principle:
Principle #3Local quality

4Productivity

If nanocomposite conjugates are produced, then cellular target binding is achieved, but rapid purification is not available

Engineering Contradiction:
Improvepurification speedVSAvoidpurification protocol complexity
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The patent utilizes the optical properties (fluorescence emission wavelengths) of the quantum dots as a detection and purification marker. The quantum dots emit light at specific wavelengths (420-1000 nm) that can be used for flow cytometry detection and magnetic separation, enabling rapid purification of nanocomposite conjugates bound to cellular targets.

Inventive Principle:
Principle #32Color changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables large batch production of nanocomposites with uniform size and brightness, high binding specificity, and rapid purification, facilitating applications like cellular target binding and macrophage targeting.

Implementation Method 1

a hydrophobic nanoparticle encapsulated in a hydrophobic region of a polymer with the external hydrophilic region of the polymer ensuring water-solubility

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 2

SPION nanocomposite antibody conjugates bound to the cells can be separated and isolated by influence of a magnetic field

Methodology Applied
Scientific EffectSuperparamagnetism: Superparamagnetism

Data Source

PatentUS12370266B2Polymer composite nanomaterial encapsulation system
Publication Date: 2025.07.29 CORE QUANTUM TECHNOLOGIES INC
  • US12370266B2 patent drawing
  • US12370266B2 patent drawing
  • US12370266B2 patent drawing

AI summary

Generally, a polymer nanomaterial encapsulation system useful in the production of polymer encapsulated nanoparticles comprised of a hydrophobic nanoparticle encapsulated in the hydrophobic region of the polymer with the external hydrophilic region of the polymer ensuring water-solubility and affording a functional group which can be utilized for the production of nanoparticle conjugates. Specifically, particular embodiments include a polymer nanoparticle structure including one or more of: a quantum dot and/or a superparamagnetic iron oxide nanoparticle and/or an upconverting nanoparticle, encapsulated in polystyrene-b-polyethylene glycol amine for the production of antibody conjugates useful in the capture of cellular targets.